| Literature DB >> 29936125 |
Christopher W Kahler1, Anthony Surace2, Rebecca E F Gordon2, Patricia A Cioe2, Nichea S Spillane3, Acacia Parks4, Beth C Bock5, Richard A Brown6.
Abstract
BACKGROUND: Despite reductions in cigarette smoking in the U.S., improvements in the efficacy of smoking cessation treatments are needed, as rates of sustained abstinence remain disappointingly low. Both low positive affect and high negative affect contribute to smoking relapse and constitute viable targets for smoking cessation interventions. Although some clinical trials have evaluated interventions to address depression as a smoking relapse risk factor, very few have focused on positive affect. Recently, we developed and conducted a preliminary clinical trial of a smoking cessation treatment that targets positive affect and cognitions by incorporating interventions rooted in positive psychology. The current randomized controlled trial will expand upon this preliminary trial to test whether this positive psychology-informed approach results in higher smoking cessation rates compared to a time-matched standard smoking cessation treatment control.Entities:
Keywords: Positive psychology; Positive psychotherapy; Smoking; Smoking cessation; Text messaging
Mesh:
Year: 2018 PMID: 29936125 PMCID: PMC6484849 DOI: 10.1016/j.cct.2018.06.013
Source DB: PubMed Journal: Contemp Clin Trials ISSN: 1551-7144 Impact factor: 2.226